吉非贝齐（CI - 719）的脂肪动力学研究。
Lipokinetic studies with gemfibrozil (CI-719).
作者信息
Kissebah A H, Adams P A, Wynn V
出版信息
Proc R Soc Med. 1976;69 Suppl 2(Suppl 2):94-7. doi: 10.1177/00359157760690S224.
Abstract
Gemfibrozil (CI-719) has proved to be an effective agent in reducing the plasma triglyceride levels in experimental animals and in patients with endogenous hypertriglyceridaemia. We have confirmed these findings.
摘要
吉非贝齐（CI - 719）已被证明是一种有效降低实验动物和内源性高甘油三酯血症患者血浆甘油三酯水平的药物。我们已证实了这些发现。
Zotero 插件